EcoDrugPlus

Ensembl ID : ENSOJAG00000011574
Gene Symbol: -
Cross references: -
258 Possible Orthologues:

Ensembl ID : ENSOJAG00000015140
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSOJAG00000012374
Gene Symbol: RPS8A
1 Cross references
325 Possible Orthologues:

Ensembl ID : ENSOJAG00000008232
Gene Symbol: PSENEN
1 Cross references
183 Possible Orthologues:

Ensembl ID : ENSOJAG00000018301
Gene Symbol: -
1 Cross references
200 Possible Orthologues:

Ensembl ID : ENSOJAG00000016946
Gene Symbol: RPL8
1 Cross references
276 Possible Orthologues:

Ensembl ID : ENSOJAG00000017899
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSOJAG00000016085
Gene Symbol: -
Cross references: -
400 Possible Orthologues:

Ensembl ID : ENSOJAG00000015982
Gene Symbol: -
Cross references: -
400 Possible Orthologues:

Ensembl ID : ENSOJAG00000017082
Gene Symbol: PARP1
1 Cross references
209 Possible Orthologues:

Ensembl ID : ENSOJAG00000005634
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSOJAG00000005966
Gene Symbol: -
Cross references: -
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).